New immunotherapy cocktail shows promise for tough lung cancer
NCT ID NCT04736173
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 33 times
Summary
This study tests a combination of two immune-boosting drugs (zimberelimab and domvanalimab) as a first treatment for people with advanced non-small cell lung cancer that has high levels of a protein called PD-L1. The goal is to see if the combo helps control the cancer longer than standard treatments. About 169 participants will be followed for cancer progression, survival, and side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Columbus, Georgia, 31904, United States
-
Research Site
Kingwood, Texas, 77339, United States
-
Research Site
Blacksburg, Virginia, 24014, United States
-
Research Site
Hong Kong, Hong Kong
-
Research Site
Johor Bahru, Malaysia
-
Research Site
Kuala Lumpur, Malaysia
-
Research Site
Kuantan, Malaysia
-
Research Site
Kuching, Malaysia
-
Research Site
Pulau Pinang, Malaysia
-
Research Site
Putrajaya, Malaysia
-
Research Site
Davao City, Philippines
-
Research Site
Manila, Philippines
-
Research Site
George, South Africa
-
Research Site
Johannesburg, South Africa
-
Research Site
Pretoria, South Africa
-
Research Site
Daegu, South Korea
-
Research Site
Incheon, South Korea
-
Research Site
Jinju, South Korea
-
Research Site
Seoul, South Korea
-
Research Site
Suwon, South Korea
-
Research Site
Taichung, Taiwan
-
Research Site
Bangkok, Thailand
-
Research Site
Changwat Sara Buri, Thailand
-
Research Site
Chanthaburi, Thailand
-
Research Site
Chiang Mai, Thailand
-
Research Site
Khon Kaen, Thailand
-
Research Site
Lampang, Thailand
-
Research Site
Nakhon Nayok, Thailand
-
Research Site
Nakhon Ratchasima, Thailand
-
Research Site
Phitsanulok, Thailand
-
Research Site
Songkhla, Thailand
-
Research Site
Ubon Ratchathani, Thailand
-
Research Site
Adana, Turkey (Türkiye)
-
Research Site
Ankara, Turkey (Türkiye)
-
Research Site
Edirne, Turkey (Türkiye)
-
Research Site
Istanbul, Turkey (Türkiye)
-
Research Site
Kocaeli, Turkey (Türkiye)
-
Research Site
Hanoi, Vietnam
-
Research Site
Huế, Vietnam
Conditions
Explore the condition pages connected to this study.